These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 19221040)

  • 1. Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease.
    Pillai AB; George TI; Dutt S; Strober S
    Blood; 2009 Apr; 113(18):4458-67. PubMed ID: 19221040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4-dependent mechanism.
    Leveson-Gower DB; Olson JA; Sega EI; Luong RH; Baker J; Zeiser R; Negrin RS
    Blood; 2011 Mar; 117(11):3220-9. PubMed ID: 21258007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recipient myeloid-derived immunomodulatory cells induce PD-1 ligand-dependent donor CD4+Foxp3+ regulatory T cell proliferation and donor-recipient immune tolerance after murine nonmyeloablative bone marrow transplantation.
    van der Merwe M; Abdelsamed HA; Seth A; Ong T; Vogel P; Pillai AB
    J Immunol; 2013 Dec; 191(11):5764-76. PubMed ID: 24190658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+ invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T cells.
    Schneidawind D; Pierini A; Alvarez M; Pan Y; Baker J; Buechele C; Luong RH; Meyer EH; Negrin RS
    Blood; 2014 Nov; 124(22):3320-8. PubMed ID: 25293774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells.
    Lan F; Zeng D; Higuchi M; Higgins JP; Strober S
    Biol Blood Marrow Transplant; 2003 Jun; 9(6):355-63. PubMed ID: 12813443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease.
    Pierini A; Colonna L; Alvarez M; Schneidawind D; Nishikii H; Baker J; Pan Y; Florek M; Kim BS; Negrin RS
    J Immunol; 2015 Jul; 195(1):347-55. PubMed ID: 25994967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host NKT cells can prevent graft-versus-host disease and permit graft antitumor activity after bone marrow transplantation.
    Pillai AB; George TI; Dutt S; Teo P; Strober S
    J Immunol; 2007 May; 178(10):6242-51. PubMed ID: 17475852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells.
    Shin HJ; Baker J; Leveson-Gower DB; Smith AT; Sega EI; Negrin RS
    Blood; 2011 Aug; 118(8):2342-50. PubMed ID: 21734238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
    Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease.
    Kim BS; Nishikii H; Baker J; Pierini A; Schneidawind D; Pan Y; Beilhack A; Park CG; Negrin RS
    Blood; 2015 Jul; 126(4):546-57. PubMed ID: 26063163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of Graft-Versus-Host Disease Control Efficacy by Adoptive Transfer of Type 1 Regulatory T Cells in Bone Marrow Transplant Model.
    Jeon YW; Lim JY; Im KI; Kim N; Nam YS; Song YJ; Cho SG
    Stem Cells Dev; 2019 Jan; 28(2):129-140. PubMed ID: 30381994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helminth-Induced Production of TGF-β and Suppression of Graft-versus-Host Disease Is Dependent on IL-4 Production by Host Cells.
    Li Y; Guan X; Liu W; Chen HL; Truscott J; Beyatli S; Metwali A; Weiner GJ; Zavazava N; Blumberg RS; Urban JF; Blazar BR; Elliott DE; Ince MN
    J Immunol; 2018 Nov; 201(10):2910-2922. PubMed ID: 30291167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].
    Cao J; Li L; Chen C; Zeng LY; Li ZY; Pan XY; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):83-8. PubMed ID: 21429372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
    Giorgini A; Noble A
    J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bidirectional immune tolerance in nonmyeloablative MHC-mismatched BMT for murine β-thalassemia.
    E S; Seth A; Vogel P; Sommers M; Ong T; Pillai AB
    Blood; 2017 Jun; 129(22):3017-3030. PubMed ID: 28351935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host Foxp3+CD4+ Regulatory T Cells Act as a Negative Regulator of Dendritic Cells in the Peritransplantation Period.
    Inoue T; Ikegame K; Kaida K; Okada M; Yoshihara S; Tamaki H; Fujimori Y; Soma T; Ogawa H
    J Immunol; 2016 Jan; 196(1):469-83. PubMed ID: 26621858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice.
    Ganguly S; Ross DB; Panoskaltsis-Mortari A; Kanakry CG; Blazar BR; Levy RB; Luznik L
    Blood; 2014 Sep; 124(13):2131-41. PubMed ID: 25139358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NKT cells, Treg, and their interactions in bone marrow transplantation.
    Kohrt HE; Pillai AB; Lowsky R; Strober S
    Eur J Immunol; 2010 Jul; 40(7):1862-9. PubMed ID: 20583031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked in Vivo Donor Regulatory T Cell Expansion via Interleukin-2 and TL1A-Ig Stimulation Ameliorates Graft-versus-Host Disease but Preserves Graft-versus-Leukemia in Recipients after Hematopoietic Stem Cell Transplantation.
    Wolf D; Barreras H; Bader CS; Copsel S; Lightbourn CO; Pfeiffer BJ; Altman NH; Podack ER; Komanduri KV; Levy RB
    Biol Blood Marrow Transplant; 2017 May; 23(5):757-766. PubMed ID: 28219835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A glucocorticoid amplifies IL-2-induced selective expansion of CD4(+)CD25(+)FOXP3(+) regulatory T cells in vivo and suppresses graft-versus-host disease after allogeneic lymphocyte transplantation.
    Xie Y; Wu M; Song R; Ma J; Shi Y; Qin W; Jin Y
    Acta Biochim Biophys Sin (Shanghai); 2009 Sep; 41(9):781-91. PubMed ID: 19727527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.